Suppr超能文献

内皮细胞活化与慢性移植物排斥反应。

Endothelial activation and chronic allograft rejection.

作者信息

Orosz C G

机构信息

Department of Surgery, Ohio State University Hospital, Columbus 43210.

出版信息

Clin Transplant. 1994 Jun;8(3 Pt 2):299-303.

PMID:7520304
Abstract

Microvascular endothelial cells are actively involved in acute and hyperacute allograft rejection. In acute rejection, inflamed graft endothelia increase their expression of cell adhesion and antigen-presentation molecules, thereby initiating and promoting various mechanisms of cellular immune rejection. In hyperacute rejection, preformed antibodies bind to graft endothelial cells and initiate endothelial procoagulant activity. These disparate immune responses appear to reflect different manifestations of endothelial cell activation. We hypothesize that chronic allograft rejection is a third manifestation of local endothelial activation. Chronic rejection is associated with interstitial and/or vascular hypertrophy. It is intriguing that among the products of activated endothelial cells are extracellular matrix components and growth factors that promote tissue reconstruction. This suggests that chronic or repetitive stimulation of endothelial cells may cause persistent or periodic release of these growth factors, eventually leading to the histopathology of chronic rejection. Chronic endothelial stimulation could be accomplished by drugs, alloantibodies, immune mediators, or some combination thereof. This leads to the question: Do different patterns of endothelial stimulation result in different manifestations of endothelial activation? Our studies of acute rejection mechanisms in murine cardiac allografts demonstrated that several stable endothelial phenotypes can develop during graft inflammation, depending on the availability of local immune stimuli (Transplantation 1993: 55: 315). Unpublished studies suggest that the steroids prednisolone and dexamethasone can synergize in vitro with suboptimal concentrations of interferon-gamma (IFN-gamma) to promote the activation of human endothelial cell lines, as manifested by enhanced expression of MHC class II but not ICAM-1. These steroids do not influence tumor necrosis factor-alpha (TNF-alpha)-induced endothelial behavior.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

微血管内皮细胞积极参与急性和超急性同种异体移植排斥反应。在急性排斥反应中,炎症状态下的移植内皮细胞会增加其细胞黏附分子和抗原呈递分子的表达,从而启动并促进细胞免疫排斥的各种机制。在超急性排斥反应中,预先形成的抗体与移植内皮细胞结合并启动内皮促凝活性。这些不同的免疫反应似乎反映了内皮细胞活化的不同表现形式。我们推测慢性同种异体移植排斥反应是局部内皮细胞活化的第三种表现形式。慢性排斥反应与间质和/或血管肥大有关。有趣的是,活化内皮细胞的产物中包括促进组织重建的细胞外基质成分和生长因子。这表明对内皮细胞的慢性或反复刺激可能导致这些生长因子持续或周期性释放,最终导致慢性排斥反应的组织病理学改变。慢性内皮细胞刺激可通过药物、同种异体抗体、免疫介质或它们的某种组合来实现。这就引出了一个问题:不同模式的内皮细胞刺激是否会导致内皮细胞活化的不同表现形式?我们对小鼠心脏同种异体移植急性排斥反应机制的研究表明,在移植炎症过程中,根据局部免疫刺激的可获得性,可出现几种稳定的内皮细胞表型(《移植》1993年:55:315)。未发表的研究表明,类固醇泼尼松龙和地塞米松在体外可与次优浓度的干扰素-γ(IFN-γ)协同作用,促进人内皮细胞系的活化,表现为MHC II类分子而非细胞间黏附分子-1(ICAM-1)表达增强。这些类固醇不影响肿瘤坏死因子-α(TNF-α)诱导的内皮细胞行为。(摘要截选至250词)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验